Monoaminergic neurotransmission is greatly dependent on the function of the vesicular monoamine transporter VMAT2, which is responsible for loading monoamines into secretory vesicles. The role of VMAT2 in histaminergic neurotransmission is poorly understood. We studied the structure and function of the histaminergic system in larval zebrafish following inhibition of VMAT2 function by reserpine. We found that reserpine treatment greatly reduced histamine immunoreactivity in neurons and an almost total disappearance of histamine-containing nerve fibers in the dorsal telencephalon and habenula, the most densely innervated targets of the hypothalamic histamine neurons. The reserpine treated larvae had an impaired histamine-dependent dark-induced flash response seen during the first second after onset of darkness, implying that function of the histaminergic network is VMAT2 dependent. Levels of histamine and other monoamines were decreased in reserpine treated animals. This study provides conclusive evidence of the relevance of VMAT2 in histaminergic neurotransmission, further implying that the storage and release mechanism of neural histamine is comparable to that of other monoamines. Our results also reveal potential new insights about the roles of monoaminergic neurotransmitters in the regulation of locomotion increase during adaptation to darkness.The function of most monoamine neurotransmitters is dependent on the vesicular release made possible by the vesicular monoamine transporter 2 (VMAT2). Serotonin and dopamine are loaded into secretory vesicles by VMAT2, and inhibition of VMAT2 leads to rapid depletion of these neurotransmitters through metabolism by the enzyme monoamine oxidase (MAO)1 . Since noradrenaline is synthesized from dopamine inside secretory vesicles 2 , VMAT2 inhibition also lowers noradrenaline levels 1 . VMAT2 inhibition by the indole alkaloid reserpine was previously used as a treatment for psychotic conditions 3 . Depression has often been reported as a side-effect of reserpine treatment, which was a key factor in the development of the monoamine depletion theory of depressive disorders and the reserpine treated animal model for depression, although the monoamine hypothesis has recently been challenged [4][5][6] . Taken together, these findings underline the significance of monoamine dependent neurotransmission in brain physiology.The role of VMAT2 in histaminergic neurotransmission remains unclear. Like the other monoamines, histamine has been described as a substrate for VMAT2 7 . In gastric enterochromaffin-like (ECL) cells, histamine storage is controlled by reserpine 8 , and reserpine induces changes in vesicle morphology and subcellular distribution of histamine 9 . However, histamine is not known to be significantly metabolized by MAO, but is rather metabolized by histamine N-methyltransferase (HNMT) in the brain, followed by subsequent metabolism by MAO 10,11 . In an explant culture from fetal rat hypothalamus, most histamine-immunoreactive neurons display VMAT2-immunoreactivity, w...